跳至主要内容
临床试验/NCT00757835
NCT00757835已完成4 期

24-hour IOP Control With the Travoprost/Timolol Fixed Combination Compared With the Latanoprost/Timolol Fixed Combination, When Both Are Dosed in the Evening in Patients With Exfoliative Glaucoma

Aristotle University Of Thessaloniki0 个研究点目标入组 40 人开始时间: 2008年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
40
主要终点
Travoprost/timolol fixed combination will demonstrate better quality of 24-hour IOP control than latanoprost/timolol

研究概览

简要总结

A crossover, randomized, single-masked study which compares the short-term (3 months) 24-hour IOP control and safety of travoprost/timolol fixed combination given once in the evening, versus that of latanoprost/timolol fixed combination given once in the evening in patients with exfoliative glaucoma. The primary objective of this trial is to compare the quality of 24-hour IOP control after 3 months of chronic therapy with these two medications.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
21 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient has XFG and is older than 29 years
  • The IOP without treatment is greater than 25 mm Hg and lower than 40 mm Hg at baseline (2 readings at 10:00)
  • Patient can be safely washed out without risk for significant deterioration
  • Distance best corrected Snelen visual acuity better than 0.1
  • No contraindication to prostaglandins or β-blockers
  • No history of lack of response (<10% reduction) to any medication
  • Patient can understand the instructions and comply to medications
  • Open normal appearing angles
  • No sign of ocular infection, except blepharitis, corneal abnormality that may affect IOP measurements etc

排除标准

  • History of trauma, inflammation, surgery, past use of steroids (within 2 months), severe dry eyes and use of contact lenses
  • Patient is a female of childbearing potential or lactating mother

研究组 & 干预措施

Travoprost/timolol therapy

Active Comparator

treatment with travoprost/timolol fixed combination drops once in the evening for 3 months. 24-hour pressure monitoring.

干预措施: treatment with latanoprost/timolol fixed combination (Drug)

Travoprost/timolol therapy

Active Comparator

treatment with travoprost/timolol fixed combination drops once in the evening for 3 months. 24-hour pressure monitoring.

干预措施: latanoprost/timolol fixed combination drops (Drug)

Latanoprost/timolol therapy

Active Comparator

Treatment with latanoprost/timolol fixed combination for 3 months. 24-hour pressure monitoring.

干预措施: treatment with latanoprost/timolol fixed combination (Drug)

Latanoprost/timolol therapy

Active Comparator

Treatment with latanoprost/timolol fixed combination for 3 months. 24-hour pressure monitoring.

干预措施: latanoprost/timolol fixed combination drops (Drug)

结局指标

主要结局

Travoprost/timolol fixed combination will demonstrate better quality of 24-hour IOP control than latanoprost/timolol

时间窗: 3 months

次要结局

  • Incidence of side effects with the two medications(3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

AGP Konstas

Professor in Ophthalmology

Aristotle University Of Thessaloniki

相似试验